Industry
-
News
Researchers collaborate for early monitoring of tar spot disease in corn
Insignum AgTech has begun a collaboration with researchers in Purdue University’s College of Agriculture and College of Engineering to create tools for farmers to identify early stages of tar spot disease outbreaks in their corn plants.
-
News
FedEx opens first European Life Science Center in Veldhoven
Federal Express Corporation, the world’s largest express transportation company, has opened its first European Life Science Center in Veldhoven, the Netherlands. The specialised cooling facility opens global access for the healthcare industry.
-
News
Enzyme-embedded PLA plastic can degrade in home-compost or methanization conditions.
A new enzyme-embedded material is proven to fully distintegrate and biodegrade at a much faster rate than the 26-week home-compost certification requirement and is shown to help produce more biomethane, another source of waste recovery.
-
News
SRI is developing a new malaria treatment that aims to protect from the disease
The injectable formulation is affordable, easily administered, and could potentially provide months of protection from the potentially fatal disease.
-
News
Highly pathogenic avian influenza A(H5N1) outbreak in Finnish fur farms
Highly pathogenic avian influenza (HPAI) A(H5N1) has been detected in animals on 27 fur farms in Finland. The outbreak, traced to wild birds, revealed significant virus adaptation to mammals and caused severe inflammation in the lungs, brains and livers.
-
News
Microbial agricultural inoculants market set to grow by $243.73 million from 2024-2028
The global microbial agricultural inoculants market size is estimated to grow by USD 243.73 million from 2024-2028, according to Technavio, with rising concerns over use of chemical fertilizers and pesticides in agriculture.
-
News
Rapid test for UTI wins $10m Longitude Prize on AMR to transform fight against superbugs
Sysmex Astrego’s PA-100 AST System has won the $10m (£8m) Longitude Prize on AMR. The winning test provides accurate antibiotic susceptibility results in 45 minutes – compared to the 2-3 day wait patients currently face.
-
News
AI enables faster, more effective antibiotic treatment of sepsis
Sepsis is a life-threatening infection complication and accounts for 1.7 million hospitalizations and 350,000 deaths annually in the U.S. Fast and accurate diagnosis is critical, as mortality risk increases up to 8% every hour without effective treatment. Source: Ilanaer42 However, the current diagnostic standard is reliant on ...
-
News
Collaboration garners new support to tackle high-value tuberculosis targets
A groundbreaking collaboration will combat global health challenges in tuberculosis through innovative technology.
-
News
IVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
News
Researchers call for regulation of direct-to-consumer microbiome tests
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
-
News
AMI unveils plans to launch educational series The Microbiologist Masterclass
Applied Microbiology International has announced it will be launching a new series of educational online content called The Microbiologist Masterclass. AMI will be teaming up with industry partners to present this series of educational assets including webinars, ‘how-to’ guides and the latest product information, plus practical tips and tricks to ...
-
News
SK bioscience’s typhoid conjugate vaccine achieves WHO prequalification
SK bioscience and the International Vaccine Institute (IVI) announced that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ).
-
News
Biotech start-up BugBiome secures investment for research in sustainable pest protection
BugBiome, a biotech harnessing nature’s microbial defences for pest protection to benefit human and planet health, has successfully closed a pre-seed funding round, securing £310k from Cambridge Angels and Discovery Park Ventures.
-
News
CARB-X funds Visby Medical to develop a portable rapid diagnostic for gonorrhea
Visby Medical aims to improve patients’ health outcomes and increase the lifespan of the last remaining antibiotic for resistant gonorrhea.
-
News
Valneva vaccinates first participant in pediatric trial of single-shot Chikungunya vaccine
Valneva SE has announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine.
-
News
Novo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...
-
News
FA Bio secures £5.3m investment from Clean Growth Fund, Pymwymic and Ship2B Ventures
FA Bio, the British bio-tech company, has secured a £5.3 million tranche of investment from three European venture capital investment funds as well as existing shareholders and new private investors.
-
News
Calibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care
-
News
Industry collaboration funds development of RNA drugs against dengue fever virus
University team use patented nuclear magnetic resonance (NMR)-based screening method to identify small molecules that specifically bind to the viruses’ highly conserved RNA structures and interrupt the viral infection cycle.